Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perrone

Showing results (211-220 of 272) with videos related to

Pageof 28
Sort By:
Critical Reviews in Oncology/Hematology|August 19, 2006
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)Sandro Pignata, Ciro Gallo, Bruno Daniele, et al.
The International Journal of Biological Markers|November 8, 2024
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trialStefano Indraccolo, Simona Signoriello, Ilaria Piga, et al.
European Journal of Cancer (Oxford, England : 1990)|May 26, 2024
Harmonization of homologous recombination deficiency testing in ovarian cancer: Results from the MITO16A/MaNGO-OV2 trialCristin Roma, Riziero Esposito Abate, Alessandra Sacco, et al.
Clinical Pharmacology and Therapeutics|May 27, 2023
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and BevacizumabMaurizio Polano, Luca Bedon, Michele Dal Bo, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
A segmental duplication-mediated deletion leads to neocentromere formation in orangutansLuciana De Gennaro, DongAhn Yoo, Letizia Pistacchia, et al.
Tumori|October 30, 2016
Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statementStefania Gori, Carmine Pinto, Caterina Caminiti, et al.
Gynecologic Oncology|December 21, 2016
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trialGennaro Daniele, Domenica Lorusso, Giovanni Scambia, et al.
Scientific Reports|July 2, 2025
The BioSUD Biobank as a genomic resource for substance use disorders in ItalyRaffaella Maria Ribatti, Luciana de Gennaro, Alessia Daponte, et al.
Lung Cancer (Amsterdam, Netherlands)|May 7, 2013
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 studyAlessandro Morabito, Vittorio Gebbia, Massimo Di Maio, et al.
BMC Cancer|March 22, 2007
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trialErmelinda De Maio, Carmen Pacilio, Adriano Gravina, et al.
Pageof 28

Showing results (211-220 of 272) with videos related to

Sort By:
Pageof 28
Critical Reviews in Oncology/Hematology|August 19, 2006
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)Sandro Pignata, Ciro Gallo, Bruno Daniele, et al.
The International Journal of Biological Markers|November 8, 2024
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trialStefano Indraccolo, Simona Signoriello, Ilaria Piga, et al.
European Journal of Cancer (Oxford, England : 1990)|May 26, 2024
Harmonization of homologous recombination deficiency testing in ovarian cancer: Results from the MITO16A/MaNGO-OV2 trialCristin Roma, Riziero Esposito Abate, Alessandra Sacco, et al.
Clinical Pharmacology and Therapeutics|May 27, 2023
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and BevacizumabMaurizio Polano, Luca Bedon, Michele Dal Bo, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
A segmental duplication-mediated deletion leads to neocentromere formation in orangutansLuciana De Gennaro, DongAhn Yoo, Letizia Pistacchia, et al.
Tumori|October 30, 2016
Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statementStefania Gori, Carmine Pinto, Caterina Caminiti, et al.
Gynecologic Oncology|December 21, 2016
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trialGennaro Daniele, Domenica Lorusso, Giovanni Scambia, et al.
Scientific Reports|July 2, 2025
The BioSUD Biobank as a genomic resource for substance use disorders in ItalyRaffaella Maria Ribatti, Luciana de Gennaro, Alessia Daponte, et al.
Lung Cancer (Amsterdam, Netherlands)|May 7, 2013
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 studyAlessandro Morabito, Vittorio Gebbia, Massimo Di Maio, et al.
BMC Cancer|March 22, 2007
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trialErmelinda De Maio, Carmen Pacilio, Adriano Gravina, et al.
Pageof 28